NEW YORK, July 30, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company, commenced on The Nasdaq Stock Market on July 30, 2015.
vTv Therapeutics Inc. is engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.
“vTv Therapeutics’ commitment to drug discovery addresses the critical demand for new and effective medical solutions,” said Nelson Griggs, Executive Vice President, Listing Services at Nasdaq. “We are proud to welcome vTv Therapeutics to the Nasdaq family, and look forward to supporting the company as it embarks on its journey as a public company.”
By listing with Nasdaq, vTv Therapeutics Inc. joins many of the world’s largest and most revolutionary companies. Nasdaq is the exchange of choice to over 77 percent of health care companies listed on U.S. markets.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately $9.5 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.